Dr. Mercy Korir

Scientists have developed a new tuberculosis vaccine that can prevent adults with latent TB from developing active TB infection. The research took two years in Kenya, Zambia and South Africa. The vaccine has a 54 per cent efficacy as per the Phase 2b results. ALSO READ: Ministry moots plan to have NHIF cover TB patients “The vaccine appears to be quite safe, except from injection site reaction and flu-like symptoms that may last three to four days.

It’s a Sunday morning when we saunter into KTN News main studio. There is a political discussion on air. The guests look like they are not sure if the person they have seen is who they think he is. It is Louis Otieno. And the nostalgia in Louis’ face is palpable. “I was last here in 2012 during the run-up to the General Election,” Louis recalls. “It’s like I have been given my life back. You know, before it was like I was in a vacuum.

The Treasury has paid the storage charges for drugs whose distribution to millions at risk of going blind had been delayed for 10 months. The Ministry of Health yesterday said the consignment of Zithromax, an antibiotic used to treat trachoma, had been in a warehouse since last October, when it was delivered by a US-based organisation.